Brain+ announces additional commitments in the ongoing exercise of warrants of series TO 2 to reach now a coverage of almost 50%
· Brain+ has received additional new commitments from existing shareholders to exercise approximately 3.5 million warrants of series TO 2 · Including the previously announced commitments, total commitments in the TO 2 warrant exercise now covers almost 50% of the total number of warrants, corresponding to approximately DKK 2.7 million in proceeds
Copenhagen, Denmark, 12 October 2023 – Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S (“Brain+” or “the Company”) announces new commitments from the company’s existing shareholders to exercise warrants in the ongoing TO 2 warrant exercise